Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Feasibility of targeted capture sequencing in FFPE cancer specimens 2

ABSTRACT: Testing the feasibility of genome-scale sequencing in routinely collected formalin-fixed paraffin-embedded (FFPE) cancer specimens versus matched fresh-frozen samples using targeted pulldown capture prior to Illumina sequencing.

PROVIDER: EGAS00001000402 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Feasibility of targeted capture sequencing in routinely collected FFPE cancer specimens

Project description:Testing the feasibility of genome-scale sequencing in routinely collected formalin-fixed paraffin-embedded (FFPE) cancer specimens versus matched fresh-frozen samples using targeted pulldown capture prior to Illumina sequencing.

| EGAS00001000297 | EGA

Testing the feasibility of genome scale sequencing in routinely collected FFPE cancer specimens versus matched fresh frozen samples

Project description:Testing the feasibility of genome-scale sequencing in routinely collected formalin-fixed paraffin-embedded (FFPE) cancer specimens versus matched fresh-frozen samples using whole exome and targeted exome capture prior to Illumina sequencing.

| EGAS00001000173 | EGA

FFPE CPA Accreditation Study

Project description:FFPE CPA accreditation of genome-scale sequencing in routinely collected formalin-fixed paraffin-embedded (FFPE) cancer specimens versus matched fresh-frozen samples using targeted pulldown capture prior to Illumina sequencing.

| EGAS00001000466 | EGA

FFPE CPA Accreditation Study Part 2

| EGAS00001000692 | EGA

EGAS00001000402-sc-20150722 - samples

| EGAD00001001448 | EGA

EGAS00001000297-sc-20130221 - samples

| EGAD00001000354 | EGA

EGAS00001000692-sc-20140611 - samples

| EGAD00001000868 | EGA

EGAS00001000466-sc-20131016 - samples

| EGAD00001000678 | EGA

In-depth proteome analysis of FFPE mammary secretory carcinoma specimens

Project description:Mammary secretory carcinoma (MSC) is one of the rarest types of breast cancer accounting for less than 0.15% of all breast cancers. Traditionally, MSC is considered that it belongs to the phenotypic spectrum of basal-like triple-negative breast carcinoma (BL-TNBC). Here, we present a study of MSC formalin-fixed paraffin embedded (FFPE) tissue specimens using novel in-depth quantitative proteomic strategy.

2018-02-27 | PXD005303 | Pride